BR112018068838A2 - oclusão de fístula pancreática - Google Patents

oclusão de fístula pancreática

Info

Publication number
BR112018068838A2
BR112018068838A2 BR112018068838A BR112018068838A BR112018068838A2 BR 112018068838 A2 BR112018068838 A2 BR 112018068838A2 BR 112018068838 A BR112018068838 A BR 112018068838A BR 112018068838 A BR112018068838 A BR 112018068838A BR 112018068838 A2 BR112018068838 A2 BR 112018068838A2
Authority
BR
Brazil
Prior art keywords
pancreatic fistula
occluding
self
assembling peptide
pancreatic
Prior art date
Application number
BR112018068838A
Other languages
English (en)
Portuguese (pt)
Inventor
Kobayashi Satoru
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of BR112018068838A2 publication Critical patent/BR112018068838A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
BR112018068838A 2016-03-18 2017-03-17 oclusão de fístula pancreática BR112018068838A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662310124P 2016-03-18 2016-03-18
PCT/IB2017/000366 WO2017158432A1 (en) 2016-03-18 2017-03-17 Pancreatic fistula occlusion

Publications (1)

Publication Number Publication Date
BR112018068838A2 true BR112018068838A2 (pt) 2019-01-22

Family

ID=58672629

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018068838A BR112018068838A2 (pt) 2016-03-18 2017-03-17 oclusão de fístula pancreática

Country Status (9)

Country Link
US (1) US20200078489A1 (enExample)
EP (1) EP3429646A1 (enExample)
JP (1) JP2019508175A (enExample)
CN (1) CN109152861A (enExample)
AU (1) AU2017235871A1 (enExample)
BR (1) BR112018068838A2 (enExample)
CL (1) CL2018002644A1 (enExample)
MX (1) MX2018011120A (enExample)
WO (1) WO2017158432A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190091376A1 (en) 2016-03-18 2019-03-28 3-D Matrix, Ltd. Preventing Biological Tissue Adhesion
JP6912953B2 (ja) * 2016-06-27 2021-08-04 三洋化成工業株式会社 体液漏出防止剤
WO2020071527A1 (ja) * 2018-10-05 2020-04-09 学校法人 久留米大学 腸管における潰瘍または瘻孔の治療または予防のための医薬組成物
US20230078523A1 (en) * 2020-02-28 2023-03-16 Menicon Co., Ltd. Digestive fluid leak preventative material and organ protective material against digestion by digestive fluid
WO2021202577A1 (en) 2020-03-31 2021-10-07 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
CN111939323B (zh) * 2020-08-08 2022-06-10 武汉速普生物科技有限公司 含有透明质酸连接肽和连接蛋白末端肽的功能性多肽水凝胶及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9327010B2 (en) * 2005-04-25 2016-05-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
WO2009049022A1 (en) * 2007-10-10 2009-04-16 Ore Pharmaceuticals Inc. Method for treatment of pancreatitis
EP2345433B1 (en) * 2008-10-06 2017-03-01 3-D Matrix, Ltd. Tissue plug
JP2016513523A (ja) * 2013-03-14 2016-05-16 株式会社スリー・ディー・マトリックス 胆汁漏の処置
CN105342984A (zh) * 2014-08-21 2016-02-24 中国人民解放军总医院 一种用于治疗急性胰腺炎的可注射温敏凝胶制剂

Also Published As

Publication number Publication date
CL2018002644A1 (es) 2019-07-05
CN109152861A (zh) 2019-01-04
MX2018011120A (es) 2019-03-28
WO2017158432A1 (en) 2017-09-21
JP2019508175A (ja) 2019-03-28
US20200078489A1 (en) 2020-03-12
AU2017235871A1 (en) 2018-09-27
EP3429646A1 (en) 2019-01-23

Similar Documents

Publication Publication Date Title
BR112018068838A2 (pt) oclusão de fístula pancreática
MX2015009963A (es) Metodos y composición farmacéutica para el tratamiento y la prevención de cardiomiopatía debido a falta de energía.
CO2020001627A2 (es) Composiciones de aminoácidos para el tratamiento de lesión neuronal
CL2018000238A1 (es) Mezcla de péptidos (divisional solicitud 201601405)
CL2021000516A1 (es) Anticuerpos y/o fragmentos de los mismos que se unen específicamente a tau humano; ácidos nucleicos que los codifican; vector; células; método para producir los anticuerpos; composición farmacéutica; y uso de los mismos para inhibir la agregación de tau, y enfermedades asociadas (divisional de la solicitud no. 202001003)
BR112017023391A2 (pt) ?composição, método para preparar uma composição e métodos para melhorar a hidratação da pele?
PH12020500321A1 (en) Amino acid compositions for the treatment of liver disease
BR112018010683A8 (pt) ?composição, método para produzir uma composição, método que compreende administrar por via enteral uma substância e método para produzir um produto?
BR112016011224A2 (pt) Formulação líquida de uma proteína de fusão que compreende tnfr e região de fc
BR112016012426A2 (pt) Ponteira de conexão de um conduto flexível com ancoragem dos fios de armação por emperramento e conduto flexível
BR112015020235A2 (pt) fragmento biologicamente ativo de proteína csf-1 ou um seu homólogo, ácido nucléico, proteína de fusão, ácido nucléico isolado, vetor, célula hospedeira, método de realização da proteína de fusão do primeiro aspeto da invenção, composição, utilização de uma proteína de fusão, método de tratamento para um indivíduo sofrendo de cancro do fígado e que irá ser submetido a cirurgia, método de tratamento para um indivíduo que irá ser submetido a cirurgia de transplante de fígado, e, kit
BR112015022747A2 (pt) materiais de prevenção de obstrução gastrointestinal
BR112017009584A2 (pt) tratamento de retinite pigmentosa com n-acetilcisteína amida
BR112018010160A2 (pt) inibidor da c1 esterase humana recombinante e usos do mesmo
EP4553065A3 (en) Novel compounds for treating mitochondrial disease
BR112017008962A2 (pt) proteínas de fusão inibidoras de c1 esterase e usos das mesmas
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
MX2016007534A (es) Composicion de gel de acido hialuronico que tiene durabilidad.
BR112019006735A2 (pt) compostos e métodos para ativação da sinalização de tie2
CL2021001096A1 (es) Métodos para tratar el síndrome mielodisplásico. (divisional de la solicitud no. 202000196)
BR112017002731A2 (pt) implante, sistema e método
BR112018068941A2 (pt) prevenção de adesão de tecidos biológicos
BR112016023519A2 (pt) inibidor de sinalização de wnt/ß-catenina, composição farmacêutica e método de tratamento e/ou prevenção de uma patologia definida por malformação vascular
MX2017009325A (es) Gel intestinal de levodopa y carbidopa y metodos de uso.
BR112018068027A2 (pt) método para tratar câncer em um paciente e composição farmacêutica

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements